Literature DB >> 11960644

The differential role of spinal MHC class II and cellular adhesion molecules in peripheral inflammatory versus neuropathic pain in rodents.

S M Sweitzer1, K A White, C Dutta, J A DeLeo.   

Abstract

The present study was designed to determine the role of central expression of immunoregulatory molecules in the development and maintenance of allodynia following a peripheral inflammatory insult or nerve transection. Differential spinal expression of major histocompatibility complex (MHC) class II, platelet-endothelial cellular adhesion molecule (PECAM), intercellular adhesion molecule (ICAM) and CD4 was observed in the two injury models. Intraplantar zymosan produced transient allodynia and only PECAM and ICAM immunoreactivity. In contrast, persistent mechanical allodynia and enhanced spinal PECAM, ICAM, MHC class II and CD4 immunoreactivity was observed following peripheral nerve transection. MHC class II knockout mice exhibited attenuated allodynia following spinal nerve transection as compared to wild-type control mice. These findings suggest that central neuroimmune activation may contribute to the maintenance of neuropathic pain following peripheral L5 spinal nerve transection but not following a peripheral inflammatory insult.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11960644     DOI: 10.1016/s0165-5728(02)00036-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  19 in total

Review 1.  Purinoceptors in microglia and neuropathic pain.

Authors:  Tuan Trang; Simon Beggs; Michael W Salter
Journal:  Pflugers Arch       Date:  2006-04-22       Impact factor: 3.657

Review 2.  ATP receptors gate microglia signaling in neuropathic pain.

Authors:  Tuan Trang; Simon Beggs; Michael W Salter
Journal:  Exp Neurol       Date:  2011-11-16       Impact factor: 5.330

3.  The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy.

Authors:  Flobert Y Tanga; Nancy Nutile-McMenemy; Joyce A DeLeo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-04       Impact factor: 11.205

Review 4.  Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain.

Authors:  Tuan Trang; Simon Beggs; Michael W Salter
Journal:  Neuron Glia Biol       Date:  2012-05-22

5.  Prenatal alcohol exposure potentiates chronic neuropathic pain, spinal glial and immune cell activation and alters sciatic nerve and DRG cytokine levels.

Authors:  Shahani Noor; Joshua J Sanchez; Arden G Vanderwall; Melody S Sun; Jessie R Maxwell; Suzy Davies; Lauren L Jantzie; Timothy R Petersen; Daniel D Savage; Erin D Milligan
Journal:  Brain Behav Immun       Date:  2016-12-20       Impact factor: 7.217

6.  Spinal Inhibition of P2XR or p38 Signaling Disrupts Hyperalgesic Priming in Male, but not Female, Mice.

Authors:  Candler Paige; Gayathri Batchalli Maruthy; Galo Mejia; Gregory Dussor; Theodore Price
Journal:  Neuroscience       Date:  2018-06-18       Impact factor: 3.590

7.  Spinal activity of interleukin 6 mediates myelin basic protein-induced allodynia.

Authors:  Justin S Ko; Kelly A Eddinger; Mila Angert; Andrei V Chernov; Jennifer Dolkas; Alex Y Strongin; Tony L Yaksh; Veronica I Shubayev
Journal:  Brain Behav Immun       Date:  2016-03-09       Impact factor: 7.217

8.  CNS-infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain.

Authors:  Ling Cao; Joyce A DeLeo
Journal:  Eur J Immunol       Date:  2008-02       Impact factor: 5.532

9.  Age-related gene expression changes in lumbar spinal cord: Implications for neuropathic pain.

Authors:  Jack A Mayhew; Mitchell J Cummins; Ethan T Cresswell; Robert J Callister; Doug W Smith; Brett A Graham
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

10.  Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2.

Authors:  Catherine Abbadie; Jill A Lindia; Anne Marie Cumiskey; Larry B Peterson; John S Mudgett; Ellen K Bayne; Julie A DeMartino; D Euan MacIntyre; Michael J Forrest
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.